Search Results - "Jayne, D.R.W"

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases by van Assen, S, Elkayam, O, Agmon-Levin, N, Cervera, R, Doran, M.F, Dougados, M, Emery, P, Geborek, P, Ioannidis, J.P.A, Jayne, D.R.W, Kallenberg, C.G.M, Müller-Ladner, U, Shoenfeld, Y, Stojanovich, L, Valesini, G, Wulffraat, N.M, Bijl, M

“…Abstract Objectives To present the systematic literature review (SLR), which formed the basis for the European League Against Rheumatism (EULAR) evidence-based…”
Get full text

Intravenous immunoglobulin for ANCA‐associated systemic vasculitis with persistent disease activity by Jayne, D.R.W., Chapel, H., Adu, D., Misbah, S., O'Donoghue, D., Scott, D., Lockwood, C.M.

“…Intravenous immunoglobulin (IVIg) is a potential alternative treatment for anti‐neutrophil cytoplasm antibody (ANCA)‐associated systemic vasculitis (AASV) with…”
Get full text

Infliximab improves endothelial dysfunction in systemic vasculitis a model of vascular inflammation by BOOTH, A. D, JAYNE, D. R. W, KHARBANDA, R. K, MCENIERY, C. M, MACKENZIE, I. S, BROWN, J, WILKINSON, I. B

“…Endothelial vasomotor dysfunction and markers of systemic inflammation are independent determinants of cardiovascular risk. However, the link between clinical…”
Get full text

Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies by Chan, T M, Frampton, G, Jayne, D R, Perry, G J, Lockwood, C M, Cameron, J S

“…Ten patients with systemic vasculitis, all positive for anti-neutrophil cytoplasm antibody (ANCA), were followed for a mean of 36 weeks to determine the…”
Get more information

Efficacité des thérapies ciblant les éosinophiles chez les patients atteints de granulomatose éosinophilique avec polyangéite en fonction du statut des ANCA : analyse post-hoc de l’étude de phase 3 MANDARA by Terrier, B., Jayne, D.R.W., Hellmich, B., Merkel, P.A., Agmon-Levin, N., Nair, P., Fan, Y., Maho, E., Necander, S., Shavit, A.

“…La granulomatose éosinophilique avec polyangéite (GEPA) est une maladie inflammatoire rare, caractérisée par un asthme, une éosinophilie sanguine et tissulaire…”
Get full text

Benralizumab versus Mépolizumab pour le traitement de la granulomatose éosinophilique avec polyangéite by Wechsler, M.E., Nair, P., Terrier, B., Walz, B., Bourdin, A., Jayne, D.R.W., Jackson, D.J., Roufosse, F., Börjesson Sjö, L., Fan, Y., Jison, M., Mccrae, C., Necander, S., Shavit, A., Walton, C., Merkel, P.A.

“…L’essai MANDARA a comparé l’efficacité et la sécurité du benralizumab et du mépolizumab chez des patients atteints de granulomatose éosinophilique avec…”
Get full text

ENT involvement is related to better renal function in patients with ANCA-associated vasculitis by Rahmattulla, C., De Lind Van Wijngaarden, R.A.F., Berden, A.E., Hauer, H.A., Floßmann, O., Jayne, D.R.W., Gaskin, G., Rasmussen, N., Noël, L.H., Ferrario, F., Waldherr, R., Pusey, C.D., Hagen, E.C., Bruijn, J.A., Bajema, I.M.

Get full text

The role of biologic therapies in the management of systemic vasculitis by Chan, A.T., Floßmann, O., Mukhtyar, C., Jayne, D.R.W., Luqmani, R.A.

“…The recent development of biologic therapies capable of selectively targeting components of the immune system has revolutionised the treatment of inflammatory…”
Get full text

ANCA and predicting relapse in systemic vasculitis by Jayne, D R, Gaskin, G, Pusey, C D, Lockwood, C M

“…We studied 60 patients with ANCA-positive systemic vasculitis (SV) to assess the prognostic significance of clinical and serological features at presentation,…”
Get more information

Treatment of systemic vasculitis with pooled intravenous immunoglobulin by Jayne, D R, Davies, M J, Fox, C J, Black, C M, Lockwood, C M

“…The therapeutic effect of a course of high-dose, pooled, intravenous immunoglobulin (IVIg) on disease activity and circulating antineutrophil cytoplasm…”
Get more information

Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis by Zhao, M.H., Jayne, D.R.W., Ardiles, L.G., Culley, F., Hodson, M.E., Lockwood, C.M.

“…Cystic fibrosis (CF), a genetic disorder, is characterized by chronic pulmonary infection/inflammation which leads to respiratory failure. The presence of…”
Get full text

Cerebral vasculitis—recognition, diagnosis and management by Scolding, N.J., Jayne, D.R.W., Zajicek, J.P., Meyer, P.A.R., Wraight, E.P., Lockwood, C.M.

“…Cerebral vasculitis is a serious but uncommon condition which presents considerable difficulties in recognition, diagnosis and treatment. We studied eight…”
Get full text

Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis by Esnault, V L, Testa, A, Jayne, D R, Soulillou, J P, Guenel, J

“…We report the treatment of 5 patients with crescentic glomerulonephritis by immunoadsorption using a protein A column. Two had systemic vasculitis, 2…”
Get more information

Analysis of anti-idiotypic antibodies against anti-microsomal antibodies in patients with thyroid autoimmunity by Tandon, N, Jayne, D R, McGregor, A M, Weetman, A P

“…Anti-microsomal antibody (AMA) activity was inhibited in 14 of 16 sera and in all 12 IgG preparations from patients with postpartum thyroiditis following…”
Get more information

The specificity of anti‐neutrophil cytoplasm autoantibodies in systemic vasculitides by LAI, K. N., JAYNE, D.R.W., BROWNLEE, A., LOCKWOOD, C.M.

“…SUMMARY Autoantibodies to neutrophil cytoplasmic antigens are found in patients with small or medium‐size vessel systemic vasculitis such as Wegcner's…”
Get full text